| Total (n = 173) | no-CF group (n = 63) | CF-only group (n = 49) | AI group (n = 61) | P-value |
---|---|---|---|---|---|
Age (years) | 57.8 ± 8.8 | 55.6 ± 8.6 | 59.0 ± 9.0 | 59.2 ± 8.6 | 0.037 |
Male | 134 (77.5%) | 53 (84.1%) | 38 (77.6%) | 43 (70.5%) | 0.192 |
BMI (kg/m2) | 25.1 ± 3.0 | 25.1 ± 2.9 | 25.5 ± 3.6 | 24.8 ± 2.6 | 0.470 |
Medical history | |||||
 Hypertension | 97 (56.1%) | 32 (50.8%) | 33 (67.3%) | 32 (52.5%) | 0.168 |
 Diabetes | 45 (26.0%) | 18 (28.6%) | 10 (20.4%) | 17 (27.9%) | 0.570 |
 Dyslipidemia | 41 (23.7%) | 13 (20.6%) | 8 (16.3%) | 20 (32.8%) | 0.101 |
 CAD | 5 (2.9%) | 4 (6.3%) | 0 (0%) | 1 (1.6%) | 0.106 |
Heart failure | 23 (13.3%) | 12 (19.0%) | 5 (10.2%) | 6 (9.8%) | 0.241 |
 Stroke/SE | 24 (13.9%) | 8 (12.7%) | 11 (22.4%) | 5 (8.2%) | 0.094 |
Duration of AF (years) | 4.7 ± 5.1 | 4.6 ± 4.5 | 4.3 ± 3.8 | 5.1 ± 6.5 | 0.732 |
CHA2DS2-VASc score | 1.7 ± 1.3 | 1.7 ± 1.4 | 1.9 ± 1.3 | 1.6 ± 1.2 | 0.355 |
Baseline AAD history | Â | Â | Â | Â | 0.018 |
 None | 12 (6.9%) | 3 (4.8%) | 3 (6.1%) | 6 (9.8%) |  |
 Class Ic | 82 (47.4%) | 21 (33.3%) | 30 (61.2%) | 31 (50.8%) |  |
 Class III | 79 (45.7%) | 39 (61.9%) | 16 (32.7%) | 24 (39.3%) |  |
LVEF (%) | 57.7 ± 5.4 | 57.9 ± 5.5 | 57.9 ± 5.1 | 57.4 ± 5.6 | 0.817 |
 LA (mm) | 45.9 ± 6.5 | 46.4 ± 7.3 | 45.5 ± 4.8 | 45.6 ± 6.8 | 0.719 |
 LA ≥ 50 mm (%) | 50 (28.9%) | 23 (36.5%) | 8 (16.3%) | 19 (31.1%) | 0.058 |